Improving Medication Adherence With Telemedicine for Adults With Severe Mental Illness
Improving Medication Adherence With Telemedicine for Adults With Severe Mental Illness
复制标题
DOI：
10.1176/appi.ps.201800286
复制
发表时间：
2019-03-01
影响因子：
3.8
通讯作者：
van den Berg, Neeltje
中科院分区：
文献类型：
--
作者：
Schulze, Lara N.;Stentzel, Ulrike;van den Berg, Neeltje
目的：该研究评估了电话和短信干预，以改善严重精神疾病患者的药物治疗依从性。方法：进行了一项随机临床试验，精神分裂症或双相情感障碍门诊患者被分配到干预组或常规护理对照组。干预由受过训练的护士提供。服药依从性测量与服药依从性报告Scale.Results：研究样本包括120名参与者。Logistic回归分析显示，干预组参与者在6个月时比对照组参与者更有可能坚持服药（比值比=4.11，p= 0.007）。干预的优势出现在4至6个月。社会愿望，诊断和药物治疗并没有影响results.Conclusions：远程医疗通过电话可以提供低阈值的支持，否则谁是在6个月后，他们的精神药物治疗的高风险进行性不遵守的患者。
Objective: The study evaluated a telephone call and text message intervention to improve adherence to medication among patients with severe mental illness.Methods: A randomized clinical trial was conducted, and outpatients with schizophrenia or bipolar disorder were assigned to the intervention group or to a usual care control group. The intervention was provided by trained nurses. Medication adherence was measured with the Medication Adherence Report Scale.Results: The study sample comprised 120 participants. Logistic regression analysis showed that intervention group participants were significantly more likely than control group participants to be medication adherent at 6 months (odds ratio=4.11, p=.007). The superiority of the intervention emerged during months 4 to 6. Social desirability, diagnosis, and medication did not affect the results.Conclusions: Telemedicine via telephone can deliver low-threshold support to patients who are otherwise at high risk of progressive nonadherence to their psychotropic medication after 6 months.